HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $318,000 | -50.3% | 6,000 | +4.2% | 0.01% | -61.5% |
| Q1 2021 | $640,000 | -32.6% | 5,760 | -47.0% | 0.01% | -45.8% |
| Q3 2020 | $949,000 | -88.4% | 10,868 | -88.1% | 0.02% | -83.1% |
| Q2 2020 | $8,171,000 | +177.6% | 91,237 | +256.2% | 0.14% | +222.7% |
| Q4 2019 | $2,943,000 | +51.8% | 25,617 | +66.7% | 0.04% | +10.0% |
| Q3 2019 | $1,939,000 | +132.8% | 15,371 | +61.3% | 0.04% | +100.0% |
| Q1 2019 | $833,000 | -47.3% | 9,530 | -31.0% | 0.02% | -31.0% |
| Q3 2018 | $1,582,000 | +649.8% | 13,803 | +192.8% | 0.03% | +866.7% |
| Q3 2017 | $211,000 | -31.0% | 4,714 | -50.3% | 0.00% | -57.1% |
| Q3 2015 | $306,000 | -61.5% | 9,493 | -50.6% | 0.01% | -53.3% |
| Q2 2015 | $795,000 | -26.3% | 19,218 | -25.0% | 0.02% | -72.2% |
| Q4 2013 | $1,079,000 | +365.1% | 25,611 | +356.3% | 0.05% | +315.4% |
| Q2 2013 | $232,000 | – | 5,613 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |